3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase EARLY_PHASE1
1
Status
Unknown
2
Terminated
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Gastrointestinal
54
Gynecologic
53
Thoracic
3
Other solid neoplasm
3
Sarcoma
2
Other neoplasm
2
Genitourinary
2
Conditions
Stomach Neoplasms
2
Ovarian Neoplasms
2
Mesothelioma
2
Fallopian Tube Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Peritoneal Neoplasms
1
Pelvic Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Liposarcoma
1
Gastrointestinal Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
Carboplatin
1145
Cisplatin
874
Pemetrexed
832
pembrolizumab
604
Paclitaxel
597
Docetaxel
535
Gemcitabine
424
Radiotherapy
374
Erlotinib Hydrochloride
367
Nivolumab
322
Bevacizumab
322
Etoposide
294
durvalumab
254
Drug Therapy
233
osimertinib
217
atezolizumab
207
Radiosurgery
188
Gefitinib
177
Vinorelbine
145
130-nm albumin-bound paclitaxel
123
Magnetic Resonance Spectroscopy
120
Ipilimumab
118
Cetuximab
113
anlotinib
104
tislelizumab
103
Topotecan
101
Cyclophosphamide
101
Taxes
99
Irinotecan
95
Albumin-Bound Paclitaxel
92
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Interventional
×
Hyperthermic Intraperitoneal Chemotherapy
×
Thoracic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled
NCT02349958
2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2
Unknown
200 enrolled
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled